CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Pharma
Original article

A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%

EarningsPositive
AI Analysis

Summary

CERS reported H1 2026 results with 7.4% organic revenue growth and adjusted EBIT margin of 18.8%, driven by gains in both companion animal (+10.0%) and farm animal (+6.7%) segments.

Financial Highlights

Revenue

+7.4% organic growth

Importance:3/10
Sentiment:
0.65
earningsrevenue_growthH1_2026_resultscompanion_animalfarm_animal
Related Companies

Read the original article

Published by PR Newswire Pharma on September 17, 2026 4:04 PM

Read Original